메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Clarity signs copper-67 Supply Agreement with Nusano

SYDNEY, Oct. 16, 2025 -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supply Agreement for copper-67 with Nusano, Inc. ("Nusano"). Nusano's 190,000 square foot state-of-the-art facility in West Valley City, Utah is expected to begin operations in late 2025 with copper-67 isotope supply planned to commence in mid-2026. The propri
- 김갑성 기자
- 2025-10-16 21:04
Volpara Earns ACR® Learning Network Vendor Partner Designation

LYNNWOOD, Wash., Oct. 16, 2025 -- Volpara Health has qualified for the American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Volpara Health partnered with one of the latest graduates of the ACR ImPower Program Mammography Positioning Improvement Collaborative to identify opportunities to improve breast cancer detection through optimized mammography positioning. Poor mammogram quality contributes to undetected breast cancer, with suboptimal positioning as the primary factor leading to technically inadequate exams. In most health systems, only
- 김갑성 기자
- 2025-10-16 21:00
NYSE Content Advisory: Pre-Market Update + HPE Unveils Strategic Business Priorities

NEW YORK, Oct. 16, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + HPE Unveils Strategic Business Priorities Ashley Mastronardi delivers the pre-market update on October 16th Stocks are fractionally higher Thursday morning after the S&P 500 ended Wednesday in the green. NYSE-listed Bank of America and Morgan Stanley increased share price by over 4% following thei
- 황정호 기자
- 2025-10-16 20:55
Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis

SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies, today announced that the Cell published results from the study evaluating its independently developed fully human anti-BCMA CAR-T cell therapy, Equecabtagene Autoleucel (Eque-cel), for the treatment of progressive multiple sclerosis (PMS). This landmark study provides the world's first clinical evidence confirming the safety and efficacy of a CAR-T the
- 김갑성 기자
- 2025-10-16 20:45
Unixell Biotech reported a case study of UX-DA001, an iPSC-derived autologous cell therapy for Parkinson Diseases at MDS Congress 2025

SHANGHAI, Oct. 16, 2025 -- Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's disease (PD) and other neurological disorders, announced positive 6-month follow-up data from the first patient in its phase 1 clinical trial for UX-DA001, an iPSC-derived autologous cell therapy for PD. These data were presented on October 8th at the International Congress of Parkinson's Disease and Movement Disorders (MDS), Honolulu, USA. UX-DA001 is the world's first autologous cell therapy product for Parkinson's Disease which has both received clin
- 김갑성 기자
- 2025-10-16 20:35
마이크로밴 인터내셔널, 신임 사장으로 셔먼 맥밀런 임명

헌터스빌, 노스캐롤라이나, 2025년 10월 16일 -- 항균 및 악취 방지 솔루션 분야의 글로벌 선도 기업 마이크로밴 인터내셔널(Microban International)이 오늘 셔먼 맥밀런(Shermon McMillan)을 신임 사장으로 임명했다고 발표했다. 글로벌 포춘 500대 기업에서 성장 전략을 성공적으로 이끌어온 그는 향후 마이크로밴의 전략, 운영, 혁신 파이프라인을 이끌어 지속 가능한 성장을 추진할 예정이다. 마이크로밴의 모회사 바 브랜즈 인터내셔널(Barr Brands International)의 스콧 빌(Scott Beal) 최고경영자(CEO)는 "셔먼 맥밀런은 마이크로밴의 목표를 정확히 이해하고 이를 실현할 수 있는 전략적이고 노련한 리더"라며 "그의 리더십 아래 마이크로밴 브랜드가 한층 강화되고, 글로벌 시장에서의 선도적 위치를 유지할 것이라 확신한다"라고 말했다. 사장으로서 맥밀런은 마이크로밴 브랜드 구축 및 제품 보호 분야에서 가장 신뢰받는 브랜드로 회사의 명성을 높이는 데 주력할 예정이다. 그는 고객 중심, 혁신 실행의 우선순위화, 브랜드 자산
- 김갑성 기자
- 2025-10-16 20:16
Microban International Appoints Shermon McMillan as New President

HUNTERSVILLE, N.C., Oct. 16, 2025 -- Microban International, the global leader in antimicrobial and odor control solutions, today announced the appointment of Shermon McMillan as its new president. A seasoned global executive with a proven record of driving growth at Fortune 500 companies, McMillan will guide Microban strategy, operations and innovation pipeline toward sustainable growth. "Shermon McMillan is a strategic and experienced leader who understands Microban's goals and how to bring them to fruition," said Scott Beal, CEO at Barr Brands International
- 김갑성 기자
- 2025-10-16 20:16
NUH And NUS Launch New Molecular Imaging And Theranostic Centre To Strengthen Patient Care And Research

Powered by Singapore's first next-generation total-body PET/CT system, the new facility aims to transform diagnostics, treatment and research in cancer and beyond SINGAPORE, Oct. 16, 2025 -- The National University Hospital (NUH) and the National University of Singapore (NUS) Clinical Imaging Research Centre (CIRC) have jointly launched the Molecular Imaging and Theranostic Centre, a novel integrated clinical, education, research & development facility that brings together advanced diagnostics, targeted therapy and pioneering research. This landmark development is set
- 김갑성 기자
- 2025-10-16 17:55
MOEA DoIT Showcases 65 Cutting-Edge Technologies at TIE

[ 메디채널 김갑성 기자 ] Unveiling AI Clothing Sorting System and New Equipment for Depression Treatment TAIPEI, Oct. 16, 2025 -- The Department of Industrial Technology (DoIT) of the Ministry of Economic Affairs (MOEA) today (16th) joins forces with 12 research institutes and industry partners at the Innovation Economy Pavilion of the Taiwan Innotech Expo (TIE) to showcase 65 innovative technologies spanning smart manufacturing, net zero sustainability, and healthcare. Powered by ITRI's Digital Twin Interactive Performing Technology—the same innovation behind the Life Theater
- 김갑성 기자
- 2025-10-16 17:46
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

BOSTON and ROLLE, Switzerland, Oct. 16, 2025 -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions. SOPHiA DDM™ Digital Twins uses each patient's unique clinical, biological, imaging, and genomic data to generate a computational replica of the patient and their individual disease. Oncologists can use the virtual
- 김갑성 기자
- 2025-10-16 16:01

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 18일 18시 00분